Clinical outcomes in a cohort of patients with heparin-induced thrombocytopenia.

David J KuterBarbara A KonkleTaye H HamzaLynne UhlSusan F AssmannJoseph E KissRichard M KaufmanNigel S KeyBruce S SachaisJohn R HessPaul NessKeith R McCraeCindy LeissingerRonald G StraussJanice G McFarlandEllis NeufeldJames B BusselThomas L Ortel

Published in: American journal of hematology (2017)

HIT patients have high risks of death, limb amputation/gangrene, thrombosis, and bleeding. Non-heparin anticoagulant treatment may not benefit all patients and should be considered only after careful assessment of the relative risks of thrombosis and bleeding in individual patients.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
prognostic factors
peritoneal dialysis
atrial fibrillation
venous thromboembolism
patient reported outcomes
growth factor
diabetic rats
patient reported